Hikal Limited Share Price and Company Fundamentals
Last traded: Last Friday at 10:00 AM
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Key Metrics
PE ratio
-
PB ratio
1.79
Dividend yield
0.58%
Beta
0.34
Market cap
₹21.34B
Enterprise value
₹27.83B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 2062 |
| Website | https://www.hikal.com |
| Mailing address | Great Eastern Chambers 6th Floor Sector 11 C.B.D. Belapur Navi Mumbai 400614 India |
| Phone / Fax | 91 22 6277 0299 / |
Dividends
Dividend yield
0.58%
Dividend amount
₹1.00
Payout ratio
172.84%
5Y Avg. yield
-%
Hikal Limited paid ₹1.00 dividend and the ex-dividend date was 17 Feb 2026.The dividend payout ratio is 172.84%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HIKAL dividend payout ratio is more than 90% making it difficult for the company to maintain the dividends and increase it year by year.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Hikal Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Jai Vishwanath Hiremath | Founder & Executive Chairman | 77 | |
| Mr. Sameer Jai Hiremath | MD & Vice Chairman | 51 | |
| Mr. Kuldeep Jain | Chief Financial Officer | ||
| Mr. Rajasekhar Reddy Chintakindi | Company Secretary & Compliance Officer | ||
| Mr. Anish Dilip Swadi | Senior President of Animal Health & Business Transformation | ||
| Mr. Sarangan Suresh M.Sc | Whole Time Director | 62 | |
| Mr. Ratish Jha | President of Human Resources | ||
| Mr. Manoj Mehrotra | President of Pharmaceuticals Business | 63 | |
| Dr. T. Devanathan | Head of IP & Quality, Pharmaceuticals | ||
| Mr. Vimal Deep Kulshrestha | President of Crop Protection | 60 |
Profitability and management effectiveness
Profit margin
-0.74%
Operating margin
8.40%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Hikal Limited is 21.34B and its enterprise value is 27.83B. The enterprise value to revenue ratio of HIKAL is 1.59. The enterprise value to EBITDA ratio of HIKAL is 12.39.
The HIKAL's stocks Beta value is 0.34 making it 66% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Hikal Limited (NSE:HIKAL) Frequently Asked Questions
1. What is Hikal Limited's Stock Symbol?
Hikal Limited trades on NSE under the ticker symbol "HIKAL".
2. What is Hikal Limited's stock price today?
One share of HIKAL stock can currently be purchased for approximately ₹173.
3. How can I contact Hikal Limited?
Hikal Limited's mailing address is Great Eastern Chambers 6th Floor Sector 11 C.B.D. Belapur Navi Mumbai 400614 India. The company can be reached via phone at 91 22 6277 0299.
4. What is Hikal Limited's official website?
The official website of Hikal Limited is https://www.hikal.com.